Author:
Lan Yanqiu,Wu Dezhi,Jin Yunrui,Shui Min,Fan Xianjun
Funder
Training program of talent innovation ability of Army Medical Center of PLA
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference21 articles.
1. [Clinical value of biomarkers in diagnosis and treatment of idiopathic pulmonary fibrosis];Fan;Zhejiang Da Xue Xue Bao Yi Xue Ban,2020
2. A fatal case of coronavirus disease 2019 (COVID-19) in a patient with idiopathic pulmonary fibrosis;Rajasurya;Cureus,2020
3. Chinese herbal medicines compared with N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: protocol for a systematic review;Guo;Medicine (Baltimore),2018
4. French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis—2017 update. Short-length version;Cottin;Rev Mal Respir,2017
5. Model-based meta-analysis on the efficacy of pharmacological treatments for idiopathic pulmonary fibrosis;Chan;CPT Pharmacometrics Syst Pharmacol,2017